Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South Africa
NCT00096681 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 762
Last updated 2011-03-14
Summary
The purpose of this study is to estimate the amount of HIV and tuberculosis (TB) infection in individuals 15 years and older in the Masiphumelele township of Cape Town, South Africa. Data collected in this study will be used to predict the effect of introducing anti-HIV therapy in this community.
Conditions
- HIV Infections
- Tuberculosis
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH -
CIPRA SA
lead NETWORK
Principal Investigators
-
Linda Gail Bekker, MBChB, FCP, PhD · Department of Medicine, University of Cape Town
-
James McIntyre, MBChB, MRCOG · University of the Witwatersrand and Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-02-28
- Primary Completion
- 2005-08-31
- Completion
- 2006-02-28
More Related Trials
-
South Africa Smoking Cessation and Engagement in HIV/TB Care Care
NCT05842161 ·Status: RECRUITING ·Phase: NA
-
Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia
NCT01252537 ·Status: COMPLETED
-
TB Reduction Through ART and TB Screening Project
NCT03739736 ·Status: UNKNOWN
-
Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa
NCT06739915 ·Status: COMPLETED ·Phase: NA
-
Collision of Three Global Pandemics: the Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological and Immunological Trajectory of COVID-19 in Botswana and Namibia
NCT05268380 ·Status: COMPLETED
-
Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
NCT00091936 ·Status: COMPLETED ·Phase: NA
-
Test and Treat TB: A Proof of Concept Trial in South Africa
NCT02298309 ·Status: COMPLETED ·Phase: NA
-
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
NCT01433796 ·Status: COMPLETED
-
Prevent TB: Choice Architecture for TPT Delivery
NCT04466488 ·Status: COMPLETED ·Phase: NA
-
Comorbidities and Virologic Outcome Among Patients on Anti-retroviral Therapy in Rural Lesotho
NCT02126696 ·Status: COMPLETED
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
SEARCH SAPPHIRE Phase A: A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
NCT04810650 ·Status: COMPLETED ·Phase: NA
-
Characteristics and Outcomes of TB and HIV Co-infections
NCT06531772 ·Status: RECRUITING
-
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
NCT05342064 ·Status: RECRUITING ·Phase: NA
-
Gene Expression in HIV and Tuberculosis Co-infection
NCT01611402 ·Status: COMPLETED
-
Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study
NCT02027480 ·Status: COMPLETED
-
Evaluation of South Africa's National Adherence Strategy
NCT02536768 ·Status: COMPLETED ·Phase: NA
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
NCT04926922 ·Status: COMPLETED
-
HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes
NCT06671808 ·Status: COMPLETED
-
Examining HIV Treatment Adherence During Early Disease
NCT02419066 ·Status: COMPLETED
-
Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People
NCT00052195 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients
NCT00398996 ·Status: COMPLETED ·Phase: PHASE3
-
Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
NCT00604617 ·Status: COMPLETED
-
International HIV Antiretroviral Adherence, Resistance and Survival
NCT01596322 ·Status: COMPLETED
-
An Adaptive Randomized Controlled Trial
NCT05633056 ·Status: RECRUITING ·Phase: NA